Hana Adhami
Immunicom Inc.
About Us
Immunicom, Inc. is a privately-held medical technology company located in San Diego, CA focused on developing innovative, non-pharmaceutical approaches for treating cancer, inflammatory diseases, and autoimmune diseases. Immunicom has received FDA Breakthrough Designation to develop a blood-filtering technology for Immunicom’s patented immunotherapy solution, Immunopheresis TM. Immunopheresis has the potential to effectively treat a wide variety of cancer types including those that have not responded to other treatment strategies including other drug and biological-based immunotherapy options with possibly fewer side effects. Immunicom seeks to leverage its technology to address unmet medical needs and improve patient access and affordability of cancer and other inflammatory and autoimmune disease treatments around the world.